France uses tax to put pressure on hepatitis C drug prices

September 30, 2014 11:46 AM

24 0

PARIS (Reuters) - France will tax drugmakers whose costly hepatitis C drugs threaten to throw off course its healthcare budget, the government has said, heaping pressure on pharmaceutical companies like Gilead Sciences to cut their prices.

The Socialist government said it had designed a "progressive contribution scheme" ensuring all patients can access new and more effective treatments against the liver-destroying virus, while limiting the burden of these drugs on state finances.

Also read: U.S. Seeks to Maintain Fragile Anti-ISIS Alliance in Iraq

Read more

To category page

Loading...